Online care
An oral-progesterone assessment offer; the exact capsule, dispensing pharmacy and follow-up terms need confirmation.
What the review examines
Examine the starting price, formulation description and clinical responsibilities without treating an ingredient name as a complete prescription.
Online care
A clinician-reviewed hormone-care service; distinguish its published oral-progesterone offer from the individual prescription and full plan.
What the review examines
Read the exact capsule offer, its ingredient disclosure and subscription terms while keeping broad menopause marketing in context.
Product brand
The exact oral progesterone product label, including its own ingredients and warnings; this is not a clinic or prescribing service.
What the review examines
A review of the identified branded capsule, its labeled purposes, peanut-oil warning and updated 2026 safety information.
Online care
Online menopause care with a named progesterone pill listing; exact manufacturer, capsule ingredients, selected supply and personal eligibility remain unverified.
What the review examines
Alloy names a progesterone pill, but its supply descriptions, exact capsule identity and separate consultation terms need their own answers.
Online care
Online menopause care that explicitly includes progesterone; exact dispensed oral form, brand, excipients and product price are not established by the reviewed public record.
What the review examines
Evernow offers progesterone-related menopause care, while its public record leaves the exact oral preparation and capsule ingredients unresolved.
Online care
Online menopause care with a separately described compounded oral micronized progesterone capsule; public ingredients, Arizona exclusion and out-of-pocket pricing are source-limited, not verified supplied-product or allergy clearance.
What the review examines
Midi’s separate progesterone offer lists an oral compounded capsule, a peanut-free claim and specific inactive ingredients; those facts need their proper regulatory and clinical scope.
Online care
Virtual menopause physician and dietitian care; relevant prescribing service confirmed, exact oral progesterone product, manufacturer and pharmacy ingredients unconfirmed.
What the review examines
Gennev’s physician and dietitian service is documented, but the actual oral progesterone preparation must be established through the clinical and pharmacy discussion.
Online care
Virtual menopause service that names progesterone prescribing; no exact supplied oral product, manufacturer, strength or excipient list verified.
What the review examines
The service names FDA-approved progesterone and explains pharmacy changes, while the precise preparation and capsule ingredients remain order-specific.
Online care
Online menopause care and prescription delivery with progesterone and Prometrium capsule catalog entries; selected stock, dispensed manufacturer, personal eligibility and benefit unverified.
What the review examines
Pandia lists progesterone and Prometrium under capsules, alongside separate prescribing and prescription-transfer routes with different costs.
Online care
US virtual menopause service for its stated age range, including progesterone-related prescribing; no exact oral product, capsule manufacturer or excipient list verified.
What the review examines
Stella’s US clinic describes progesterone among its options and adds coaching and app support, while the exact pharmacy product remains a separate question.
Online care
Online menopause consultation names micronized progesterone and other oral options; actual formulation, manufacturer, pharmacy price and individual eligibility remain unverified.
What the review examines
Wisp’s consultation page names micronized progesterone and Provera within broader care, but those entries do not describe the same active drug or a completed capsule order.
Online care
Joi + Blokes hormone care lists progesterone capsules separately from cream; exact capsule formulation, approval status, excipients and personal benefit remain unconfirmed.
What the review examines
Joi’s current hormone page separates progesterone capsules from cream, while its care charges, compounding notice and lab promotions need equally careful separation.
Online care
US menopause telehealth and documented progesterone-related preparation entries; current exact capsule, ingredients, location access and full cost require confirmation.
What the review examines
A menopause service with a dated medication table, unexplained formulation codes and separate care charges; the proposed capsule still needs a complete identity.
Online care
Telemedicine menopause assessment with oral hormone capsules among several options; a particular progesterone product, formula and dispensing arrangement are not confirmed.
What the review examines
Telemedicine menopause care lists oral capsules among several delivery methods, while the actual progesterone preparation and purchase remain individual questions.
Clinic network
Clinic network and telehealth menopause care with testing and membership access; individual practitioner, exact oral capsule and complete treatment charges remain unverified.
What the review examines
A clinic and telehealth network whose testing, membership and compounding descriptions do not substitute for the label of an individual medicine.
Clinic network
Physician-led menopause program with progesterone and route discussions; exact capsule, dispensing terms and personal benefit are unresolved, and broad safety claims require qualification.
What the review examines
A menopause program that discusses oral and topical progesterone, assessed against exact product warnings and the limits of broad benefit language.
Online care
Online menopause assessment with a published compounded oral progesterone option; exact ingredients, quantity, pharmacy and personal eligibility remain unconfirmed.
What the review examines
A specific capsule entry appears in the Premium menu, with medicine charges, broad benefit claims and missing formulation details that need their own reading.
Online care
Online hormone-care service with a micronized-progesterone product page and explicit soy/peanut notice; exact oral-capsule identity and differing membership conditions remain unresolved.
What the review examines
The micronized-progesterone page names allergens and membership conditions, while route, formulation and conflicting program-price descriptions remain questions.
Online care
Menopause hormone-care program with kit and prepaid-plan descriptions; exact oral progesterone product, excipients and individual inclusion terms remain unconfirmed.
What the review examines
A menopause program with several prepaid billing periods; the kit, pharmacy choice and proposed progesterone preparation need separate answers.
Clinic network
California, Texas and Florida hormone-care access; an FDA-approved oral micronized-progesterone category is listed, while exact product and individual prescribing remain unconfirmed.
What the review examines
California, Texas and Florida access, a named oral treatment category and subscription rules that distinguish automatic billing from a refill request.
Clinic network
UK menopause consultations in person and by video; progesterone is discussed, but exact oral-capsule product, pharmacy and individual prescription remain unconfirmed.
What the review examines
Appointment prices and menopause care are documented; a specific capsule, private prescription cost and any later NHS arrangement require separate confirmation.
Health system
Regional menopause care in North Carolina; specific oral progesterone product unconfirmed.
What the review examines
Duke offers menopause care and describes several hormone treatments. Its broad route list does not identify a particular progesterone capsule.
Health system
Menopause services described in Ohio, Florida and London; location-specific access and oral product unconfirmed.
What the review examines
Cleveland Clinic describes virtual menopause groups and individual care. Its group-visit pathway does not confirm a capsule prescription or a personal ingredient review.
Health system
Minnesota and Florida specialty services; individual access and oral progesterone product unconfirmed.
What the review examines
Mayo describes menopause, sexual-health and survivorship consultations. Each clinical question needs its own assessment before a specific oral product can be discussed.
Health system
Referral-based Maryland menopause clinic; possible telemedicine for Maryland or Florida residents, subject to confirmation.
What the review examines
Hopkins describes a referral-based menopause clinic and multidisciplinary coordination. Navigation, prescribing and pharmacy ingredient checks have different responsibilities.
Health system
Menopause care at listed New York City practices; oral formulation and individual access unconfirmed.
What the review examines
Mount Sinai confirms menopause care at New York City practices. The reviewed pages do not identify an oral progesterone product, formulation or treatment price.
Health system
Chicago menopause specialty service; oral progesterone product and individual prescription unconfirmed.
What the review examines
Northwestern’s menopause program mentions off-label treatments. That does not identify a compounded medicine, a particular capsule or a prescription for an individual.
Health system
California comprehensive menopause program; individual eligibility and oral progesterone product unconfirmed.
What the review examines
UCLA’s menopause program assesses sleep among several health concerns. Its broad care description does not establish that oral progesterone is a sleep treatment for a reader.
Health system
Bay Area menopause care with in-person and video options subject to access; oral product unconfirmed.
What the review examines
Stanford explains why progesterone may accompany estrogen and lists several hormone-delivery methods. The page does not assign every route to progesterone or identify an oral product.
Health system
Utah midlife women’s health service; exact oral product and patient-specific access unconfirmed.
What the review examines
Utah describes a detailed midlife consultation. Existing medicine information can inform that discussion without establishing that the same capsule should be continued or prescribed.